Effects of Exercise During Gestation on Maternal and Foetal Health
GESTAFIT
Effects of Supervised Exercise During Gestation on Maternal and Foetal Health Markers. The GESTAFIT Project
1 other identifier
interventional
140
1 country
1
Brief Summary
The main objective of this project is to assess the effects of a novel and supervised exercise intervention in overweight pregnant and their newborn. Methods/Design: The present study is a Randomized Controlled Trial. Sixty overweight pregnant interested in participate in the intervention program will be randomly assigned to either exercise (3 sessions/week), or to usual care (control) group (30 pregnant per group). The primary outcome measures are maternal weight gain, and maternal and neonatal glycaemic profile. Secondary outcomes measure are: i) body composition; ii) dietary patterns; iii) physical fitness; iv) objectively measured physical activity and sedentary behaviour; v) sleep quality; vi) mental health, quality of life and positive health; vii) haematology and biochemical analysis; viii) oxidative stress; ix) pro- and anti-inflammatory markers; x) bone health biomarkers; xi) adiposity-related proteins expression. The data will be analysed on an intention-to-treat basis and per protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pregnancy
Started Oct 2015
Typical duration for not_applicable pregnancy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 6, 2015
CompletedFirst Posted
Study publicly available on registry
October 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedNovember 17, 2025
November 1, 2025
1.8 years
October 6, 2015
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Insulin sensitivity derived from the homeostatic model assessment for insulin resistance (HOMA-IR)
Insulin sensitivity will be derived from the homeostatic model assessment for insulin resistance (HOMA-IR), which will be calculated using the formula \[fasting insulin (μIU/mL) x fasting glucose (mg/dL)\]/405.
34th week of gestation
Maternal weight gain (kg)
Maternal weight gain will be defined as the weight change from baseline measurement to the last measurement
34th week of gestation
Neonatal insuline-glucose index
Neonatal insulin sensitivity will be assessed through the ratio glucose/insulin.
At delivery in cord blood samples
Secondary Outcomes (48)
Systolic and diastolic blood pressure (mmHg)
at the 16th and 34th week of gestation
Resting heart rate (bpm)
at the 16th and 34th week of gestation
The Mediterranean Diet Score
at the 16th and 34th week of gestation
Cardiorespiratory fitness (Vo2max)
at the 16th and 34th week of gestation
Cardiorespiratory fitness (meters in the 6-min walk test)
at the 16th and 34th week of gestation
- +43 more secondary outcomes
Study Arms (2)
Gestafitos
EXPERIMENTALThis is a longitudinal study developed, which is the continuation of the GESTAtion and FITness (GESTAFIT) Project. The main purpose is to evaluate the influence of a concurrent physical exercise program during pregnancy (developed under the GESTAFIT project) on the body composition, physical fitness, brain structure, and motor, cognitive, and language development of the offspring at four years of age.
Placentraining
EXPERIMENTALThis is a retrospective study which purpose is to analyse the status of placentas of women participating in the GESTAFIT project, in which a concurrent physical exercise programme was developed. This rigorous design will allow us to test our central hypothesis that exercise during pregnancy will produce greater improvements in placental metabolic pathways associated with pregnancy complications, and is associated with better pregnancy and newborn outcomes.
Interventions
The exercise intervention will be performed in two groups so that each group will have 12-13 participants.The groups will train 3 days/week (60min per session) from the 16th week of gestation until delivery. The exercise intervention group will go through different phases of training: a) Learning phase: which will involve the intervention plan, the goals we want to work, and how we will perform it; b) Movement Learning phase: theoretical and practical sessions with the explanation of movements and ergonomic basic patterns; and c) Physical Fitness Training phase: with training sessions aimed at improving fitness and weight loss, and training sessions focused on a correct pelvic mobilization for the delivery.The intensity will be adapted during the exercise program based on the week of gestation and each pregnant heart rate. The sessions will consist of a mixed work, composed of circuits where both muscular and cardiovascular conditioning will be implemented.
Eligibility Criteria
You may qualify if:
- Overweight pregnant woman with a normal pregnancy course.
- Answer "no" to all questions on the PARmed-X for pregnancy\*.
- To be able to walk without assistance.
- To be able to read and write enough.
You may not qualify if:
- Acute or terminal illness.
- Malnutrition.
- Inability to conduct tests for assessing physical fitness or exercise during pregnancy.
- Underweight, normal-weight or obesity.
- Pregnancy risk factors (such as hypertension, type 2 diabetes, etc.).
- Multiple pregnancies.
- Chromosopathy or foetal malformations.
- Uterine growth restriction.
- Foetal death.
- Upper or lower extremity fracture in the past 3 months.
- Presence of neuromuscular disease or drugs affecting neuromuscular function
- Be registered in other exercise program
- Perform more than 300 minutes of at least moderate physical activity per week
- Unwillingness to either complete the study requirements or to be randomised into control or intervention group.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pilar Cabello-Turmo
Granada, Granada, 18071, Spain
Related Publications (5)
Marin-Jimenez N, Baena-Garcia L, Coll-Risco I, Flor-Alemany M, Castro-Pinero J, Aparicio VA. Influence of a Concurrent Exercise Training Program on Health-Related Quality of Life During Advanced Pregnancy: The GESTAFIT Project. Sports Health. 2024 Jul-Aug;16(4):518-526. doi: 10.1177/19417381231189730. Epub 2023 Jul 31.
PMID: 37525559DERIVEDAparicio VA, Baena-Garcia L, Flor-Alemany M, Martinez-Gonzalez LJ, Varela-Lopez A, Sanchez C, Quiles JL. Differences in maternal and neonatal cardiometabolic markers and placenta status by foetal sex. The GESTAFIT project. Womens Health (Lond). 2022 Jan-Dec;18:17455057221117976. doi: 10.1177/17455057221117976.
PMID: 35989614DERIVEDBaena-Garcia L, Coll-Risco I, Ocon-Hernandez O, Romero-Gallardo L, Acosta-Manzano P, May L, Aparicio VA. Association of objectively measured physical fitness during pregnancy with maternal and neonatal outcomes. The GESTAFIT Project. PLoS One. 2020 Feb 18;15(2):e0229079. doi: 10.1371/journal.pone.0229079. eCollection 2020.
PMID: 32069319DERIVEDAparicio VA, Ocon O, Diaz-Castro J, Acosta-Manzano P, Coll-Risco I, Borges-Cosic M, Romero-Gallardo L, Moreno-Fernandez J, Ochoa-Herrera JJ. Influence of a Concurrent Exercise Training Program During Pregnancy on Colostrum and Mature Human Milk Inflammatory Markers: Findings From the GESTAFIT Project. J Hum Lact. 2018 Nov;34(4):789-798. doi: 10.1177/0890334418759261. Epub 2018 Mar 30.
PMID: 29601268DERIVEDAparicio VA, Ocon O, Padilla-Vinuesa C, Soriano-Maldonado A, Romero-Gallardo L, Borges-Cosic M, Coll-Risco I, Ruiz-Cabello P, Acosta-Manzano P, Estevez-Lopez F, Alvarez-Gallardo IC, Delgado-Fernandez M, Ruiz JR, Van Poppel MN, Ochoa-Herrera JJ. Effects of supervised aerobic and strength training in overweight and grade I obese pregnant women on maternal and foetal health markers: the GESTAFIT randomized controlled trial. BMC Pregnancy Childbirth. 2016 Sep 29;16(1):290. doi: 10.1186/s12884-016-1081-y.
PMID: 27680325DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
October 6, 2015
First Posted
October 21, 2015
Study Start
October 1, 2015
Primary Completion
July 1, 2017
Study Completion
July 1, 2018
Last Updated
November 17, 2025
Record last verified: 2025-11